| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.036 | 0.9 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |